Medtronic Gross Profit 2010-2025 | MDT
Medtronic annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Medtronic gross profit for the quarter ending April 30, 2025 was $5.781B, a 4.27% increase year-over-year.
- Medtronic gross profit for the twelve months ending April 30, 2025 was $21.905B, a 3.58% increase year-over-year.
- Medtronic annual gross profit for 2025 was $21.905B, a 3.58% increase from 2024.
- Medtronic annual gross profit for 2024 was $21.148B, a 3.12% increase from 2023.
- Medtronic annual gross profit for 2023 was $20.508B, a 4.8% decline from 2022.
| Medtronic Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $21,905 |
| 2024 | $21,148 |
| 2023 | $20,508 |
| 2022 | $21,541 |
| 2021 | $19,634 |
| 2020 | $19,489 |
| 2019 | $21,402 |
| 2018 | $20,886 |
| 2017 | $20,416 |
| 2016 | $19,691 |
| 2015 | $13,952 |
| 2014 | $12,672 |
| 2013 | $12,464 |
| 2012 | $12,295 |
| 2011 | $11,808 |
| 2010 | $11,810 |
| 2009 | $11,081 |
| Medtronic Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-04-30 | $5,781 |
| 2025-01-31 | $5,513 |
| 2024-10-31 | $5,457 |
| 2024-07-31 | $5,154 |
| 2024-04-30 | $5,544 |
| 2024-01-31 | $5,307 |
| 2023-10-31 | $5,223 |
| 2023-07-31 | $5,074 |
| 2023-04-30 | $5,565 |
| 2023-01-31 | $5,038 |
| 2022-10-31 | $5,050 |
| 2022-07-31 | $4,855 |
| 2022-04-30 | $5,498 |
| 2022-01-31 | $5,304 |
| 2021-10-31 | $5,350 |
| 2021-07-31 | $5,389 |
| 2021-04-30 | $5,536 |
| 2021-01-31 | $5,154 |
| 2020-10-31 | $4,942 |
| 2020-07-31 | $4,002 |
| 2020-04-30 | $3,733 |
| 2020-01-31 | $5,317 |
| 2019-10-31 | $5,312 |
| 2019-07-31 | $5,127 |
| 2019-04-30 | $5,663 |
| 2019-01-31 | $5,281 |
| 2018-10-31 | $5,278 |
| 2018-07-31 | $5,180 |
| 2018-04-30 | $5,746 |
| 2018-01-31 | $5,175 |
| 2017-10-31 | $4,927 |
| 2017-07-31 | $5,038 |
| 2017-04-30 | $5,477 |
| 2017-01-31 | $5,015 |
| 2016-10-31 | $5,019 |
| 2016-07-31 | $4,905 |
| 2016-04-30 | $5,204 |
| 2016-01-31 | $4,793 |
| 2015-10-31 | $4,876 |
| 2015-07-31 | $4,818 |
| 2015-04-30 | $4,370 |
| 2015-01-31 | $3,190 |
| 2014-10-31 | $3,224 |
| 2014-07-31 | $3,168 |
| 2014-04-30 | $3,394 |
| 2014-01-31 | $3,113 |
| 2013-10-31 | $3,104 |
| 2013-07-31 | $3,061 |
| 2013-04-30 | $3,326 |
| 2013-01-31 | $3,028 |
| 2012-10-31 | $3,075 |
| 2012-07-31 | $3,035 |
| 2012-04-30 | $3,250 |
| 2012-01-31 | $2,987 |
| 2011-10-31 | $3,063 |
| 2011-07-31 | $2,995 |
| 2011-04-30 | $3,063 |
| 2011-01-31 | $2,923 |
| 2010-10-31 | $2,942 |
| 2010-07-31 | $2,880 |
| 2010-04-30 | $2,988 |
| 2010-01-31 | $2,939 |
| 2009-10-31 | $2,916 |
| 2009-07-31 | $2,967 |
| 2009-04-30 | $2,897 |
| 2009-01-31 | $2,646 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $114.826B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |